Search Results for: CD95

Format
Reactivity Species
Host Species
Category
Reported Applications
10 per page
Sort by

Toggle Details

Showing 11 – 20 of 23 results Showing all 23 results Showing the single result No results found
Name
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
Lpr, APO1, APT1, CD95, TNFR6, AI196731, TNFRSF6
Reactivity:
Mouse
F1034
Max:
Min: 1
Step: 1
Alt Names:
TNFRSF6, CD95, Apo-1, Fas Antigen
Reactivity:
Human
F158
Max:
Min: 1
Step: 1
Alt Names:
Soluble Fas Ligand, soluble Fas Ligand (sFasL), TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Human
Immunogen:
Purified Recombinant Human sFasL (Accession # Q53ZZ1)
ELISA Det
,
WB
F164
Max:
Min: 1
Step: 1
Alt Names:
Soluble Fas Ligand, soluble Fas Ligand (sFasL), TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Human
Immunogen:
CHO Cell-Derived Recombinant human Fas Ligand
FC
,
IHC FFPE
,
N
,
WB
F163
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL
Reactivity:
Human
Immunogen:
Purified Recombinant Human Fas Ligand (Accession # P48023)
ELISA Cap
,
FC
,
N
F1126
100419
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Human
F115
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Mouse
F1037
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Mouse
Immunogen:
NS0-Derived Recombinant Mouse Fas Ligand
N
,
WB
F1074
101624
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Mouse
Immunogen:
Purified Recombinant Mouse FAS Ligand (>98%)
ELISA Cap
,
N
,
WB
F1075
101626
Max:
Min: 1
Step: 1
Alt Names:
TNFSF6, CD95L, Apo I Ligand, APTL, FASLG, APT1LG1, CD178
Reactivity:
Mouse
Immunogen:
NS0 - Derived Recombinant Mouse Fas Ligand (aa 132 - 279)
N
,
WB
F1088
Max:
Min: 1
Step: 1
1 2 3
Cookie Policy
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy.